Zhejiang Tongxing Technology
301252
Dongguan Dingtong Precision Metal Co.,Ltd.
688668
Hangzhou Shenhao Technology
300853
Zhejiang Changsheng Sliding Bearings
300718
SINONIC
833914
CN Stock MarketDetailed Quotes
000028 China National Accord Medicines Corporation
- 30.54
- -0.31-1.00%
Market Closed Dec 25 15:00 CST
17.00BMarket Cap11.52P/E (TTM)
30.96High30.35Low27.83KlotVolume30.85Open30.85Pre Close85.18MTurnover0.58%Turnover Ratio10.63P/E (Static)556.57MShares41.4552wk High0.94P/B14.60BFloat Cap23.8452wk Low33.94Limit Up478.05MShs Float68.54Historical High27.77Limit Down1.98%Amplitude-4.09Historical Low0.68Dividend TTM30.60Avg Price14.94KlotAsk2.23%Div YieldTTM100Lot Size12.43KlotBid
China National Accord Medicines Corporation Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 4.74%5.43B | 5.39%6.01B | -3.75%5.72B | 8.08%6.5B | -13.33%5.19B | 2.26%5.7B | 22.16%5.95B | 17.37%6.02B | 18.99%5.99B | -5.16%5.57B |
| Notes receivable and accounts receivable | 2.52%24.65B | 1.77%23.06B | 18.01%23.86B | 29.89%19.31B | 18.29%24.04B | 15.03%22.66B | 5.94%20.22B | -10.68%14.87B | 7.77%20.33B | 7.26%19.7B |
| -Notes receivable | -37.87%514.9M | -17.98%604.22M | -4.91%874.03M | 4.37%1.15B | 29.04%828.73M | 16.15%736.68M | 43.07%919.11M | 62.02%1.1B | 31.97%642.26M | 4.65%634.26M |
| -Accounts receivable | 3.96%24.13B | 2.44%22.46B | 19.10%22.99B | 31.93%18.16B | 17.94%23.21B | 14.99%21.92B | 4.65%19.3B | -13.78%13.76B | 7.13%19.68B | 7.35%19.07B |
| Other receivables (including interest and dividends) | -2.79%695.43M | 9.07%802.97M | 14.07%865.65M | 28.14%809.01M | 17.53%715.37M | 17.82%736.21M | 15.90%758.9M | -12.08%631.37M | 3.40%608.69M | -5.65%624.86M |
| -Dividend receivable | ---- | 321.08%70.38M | ---- | ---- | ---- | 0.00%16.71M | ---- | ---- | ---- | --16.71M |
| -Other receivable | ---- | 1.82%732.59M | ---- | ---- | ---- | 18.31%719.5M | ---- | -12.08%631.37M | ---- | -8.17%608.15M |
| Contractual assets | -29.09%10.49M | -35.10%10.94M | -52.06%9.38M | -41.39%10.58M | -24.06%14.79M | -40.16%16.86M | -34.20%19.56M | -37.89%18.05M | -8.55%19.48M | 65.06%28.17M |
| Advance payment | 20.05%602.43M | -8.39%505.22M | 7.82%589.91M | -26.57%620M | 6.70%501.8M | 43.57%551.48M | 14.55%547.11M | 62.08%844.33M | -18.50%470.3M | -37.60%384.13M |
| Inventories | -1.08%8.39B | -1.57%8.38B | -4.52%8.24B | 1.95%7.99B | 2.27%8.48B | 7.72%8.52B | 7.16%8.64B | 2.81%7.84B | 7.30%8.3B | 9.50%7.91B |
| Receivable financing | 23.28%722.85M | 78.54%938.54M | -11.75%590.55M | -30.61%913.98M | -16.66%586.36M | -16.84%525.68M | 42.57%669.18M | 28.23%1.32B | -5.83%703.58M | 82.74%632.1M |
| Other current assets | 4.66%172.9M | 37.41%183.46M | 30.34%170.63M | 20.46%214.62M | 48.34%165.2M | 12.11%133.51M | -7.04%130.91M | 10.93%178.16M | -5.46%111.37M | 17.23%119.09M |
| Total current assets | 2.47%40.68B | 2.71%39.89B | 8.47%40.06B | 14.70%36.37B | 8.70%39.7B | 11.07%38.84B | 9.30%36.93B | -0.44%31.71B | 8.46%36.52B | 5.30%34.97B |
| Non Current assets | ||||||||||
| Other equity investment | -2.27%30.57M | -2.27%30.57M | -2.27%30.57M | -2.27%30.57M | -49.94%31.28M | -49.94%31.28M | -49.94%31.28M | -49.94%31.28M | -37.19%62.49M | -37.19%62.49M |
| Other non-current financial assets | -26.34%148.77M | -24.09%153.33M | -18.48%153.33M | -10.30%169.39M | 48.54%201.98M | 48.54%201.98M | 38.32%188.09M | 38.88%188.85M | 0.00%135.97M | 15.26%135.97M |
| Investment real estate | -3.46%103.62M | -1.92%106.46M | -1.40%107.44M | 2.98%112.47M | -2.83%107.33M | -2.88%108.54M | -3.41%108.96M | -4.18%109.21M | -4.50%110.46M | -9.43%111.75M |
| Long-term equity investment | 8.40%2.89B | 9.00%2.89B | 7.56%2.86B | 6.51%2.75B | 7.67%2.66B | 7.16%2.65B | 6.20%2.66B | 4.84%2.58B | -1.29%2.47B | 1.81%2.47B |
| Fixed assets | ---- | 1.33%842.83M | ---- | ---- | ---- | -0.48%831.79M | ---- | -2.13%850.11M | ---- | -0.55%835.8M |
| Constru in process | ---- | -49.59%19.04M | ---- | ---- | ---- | 9.80%37.77M | ---- | -29.45%35.17M | ---- | -46.78%34.4M |
| Intangible assets | -7.62%580.97M | -7.97%593.98M | -6.83%605.38M | -4.93%615.59M | -6.34%628.9M | -5.30%645.45M | -4.22%649.76M | -3.35%647.52M | -9.05%671.48M | -9.30%681.6M |
| Goodwill | 0.00%2.75B | 0.00%2.75B | -0.12%2.75B | -0.12%2.75B | -1.04%2.75B | -1.04%2.75B | -0.93%2.75B | -0.93%2.75B | -5.33%2.78B | -5.33%2.78B |
| Long deferred expense | -3.50%502.27M | -3.67%517.86M | -5.68%514.21M | -8.03%526.58M | -9.98%520.47M | -10.98%537.61M | -12.22%545.19M | -9.69%572.55M | 5.59%578.15M | 15.43%603.91M |
| Deferred tax assets | 18.92%246.4M | 27.76%236.04M | 21.60%222.09M | 19.01%220.48M | 9.95%207.21M | -0.13%184.75M | 18.06%182.64M | 42.79%185.25M | 72.11%188.45M | 91.51%184.99M |
| Usufruct assets | 8.35%2.92B | 15.01%3.08B | 18.23%3.04B | 11.93%2.82B | 4.80%2.7B | 1.88%2.68B | -3.52%2.57B | -2.07%2.52B | -1.17%2.57B | 4.14%2.63B |
| Other non current assets | -16.76%295.69M | -23.45%298.95M | -23.83%316.26M | -29.53%307.86M | -30.07%355.24M | -17.78%390.54M | -10.94%415.23M | -5.03%436.87M | 7.66%507.98M | -1.91%474.99M |
| Total non current assets | 2.39%11.3B | 4.25%11.51B | 4.66%11.47B | 2.69%11.2B | 0.88%11.04B | 0.38%11.04B | -0.92%10.96B | -0.25%10.91B | -2.15%10.94B | 0.15%11B |
| Total assets | 2.45%51.98B | 3.05%51.41B | 7.60%51.52B | 11.63%47.57B | 6.90%50.74B | 8.51%49.88B | 6.78%47.89B | -0.39%42.62B | 5.81%47.46B | 4.02%45.97B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -2.46%4.3B | 11.71%4.44B | 11.67%3.81B | 107.27%2.61B | 52.17%4.41B | 28.29%3.98B | 12.14%3.41B | -34.70%1.26B | -11.62%2.9B | -33.11%3.1B |
| Notes payable and accounts payable | 2.48%20.6B | 0.15%19.41B | 11.10%20.05B | 17.85%17.95B | 5.22%20.1B | 9.38%19.38B | 3.90%18.05B | -8.88%15.23B | 5.58%19.11B | 7.90%17.72B |
| -Notes payable | 7.01%8.18B | 0.92%7.52B | 20.07%7.76B | 19.27%8.38B | 11.78%7.64B | 16.59%7.45B | -4.39%6.46B | -8.29%7.02B | -6.97%6.84B | -5.75%6.39B |
| -Accounts payable | -0.30%12.42B | -0.33%11.89B | 6.09%12.29B | 16.63%9.57B | 1.56%12.46B | 5.32%11.93B | 9.18%11.59B | -9.38%8.21B | 14.16%12.27B | 17.50%11.33B |
| Contract liabilities | -36.15%293.73M | -16.53%414M | -26.74%363.59M | -22.96%438.1M | 2.50%460.02M | 11.04%495.97M | 15.56%496.29M | 31.84%568.64M | 37.63%448.8M | 40.98%446.67M |
| Advance receipts | -0.65%19.74M | 5.41%19.59M | 17.03%17.23M | -0.65%18.2M | 25.02%19.87M | 2.46%18.59M | -20.81%14.72M | -5.06%18.31M | -7.83%15.9M | 22.01%18.14M |
| Salaries payable | -10.35%290.34M | -14.50%248.06M | -14.92%241.46M | -22.54%352.65M | 5.19%323.85M | 20.40%290.15M | 25.68%283.8M | 33.83%455.28M | 10.91%307.87M | -0.50%240.99M |
| Taxs payable | -12.53%296.81M | -8.93%298.89M | 3.53%317.36M | -12.79%374.08M | 7.98%339.34M | -9.24%328.21M | -0.19%306.54M | 27.22%428.93M | 12.87%314.26M | 21.26%361.61M |
| Other payable (including interest and dividends) | -12.18%1.21B | -12.37%1.75B | -22.58%1.83B | -27.87%1.51B | -35.00%1.38B | -11.02%2B | 23.60%2.36B | 21.90%2.09B | 41.35%2.12B | 46.80%2.25B |
| -Interest payable | 56.86%33.67M | 68.73%46.59M | -34.04%33.52M | --56.2M | -56.55%21.46M | -49.45%27.61M | 34.56%50.82M | ---- | 269.07%49.39M | 236.08%54.63M |
| -Dividend payable | 70.62%10.54M | 42.26%10.76M | 46.62%10.76M | 46.62%10.76M | -79.39%6.18M | -74.76%7.57M | -75.64%7.34M | -75.64%7.34M | -1.87%29.98M | 278.89%29.98M |
| -Other payable | -13.66%1.17B | -13.72%1.7B | -22.55%1.78B | -30.83%1.44B | -33.83%1.35B | -9.17%1.97B | 25.01%2.3B | 26.00%2.08B | 40.16%2.04B | 43.54%2.16B |
| Non current liabilities due within one year | 5.52%1.04B | 4.88%1.04B | 11.84%1.06B | 11.65%1.02B | 11.61%982.13M | 16.09%996.14M | 11.54%949.72M | 7.62%912.99M | 7.96%879.99M | 7.51%858.09M |
| Other current liabilities | -23.68%40.27M | -57.74%40.77M | -17.71%39.35M | 6.34%63.48M | -25.59%52.77M | 170.53%96.46M | 28.17%47.82M | 50.82%59.7M | 244.68%70.92M | 58.95%35.66M |
| Total current liabilities | 0.08%28.09B | 0.32%27.67B | 6.99%27.72B | 15.74%24.34B | 7.30%28.07B | 10.21%27.59B | 7.14%25.91B | -6.04%21.03B | 6.30%26.16B | 3.08%25.03B |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | -84.83%9.5M | -75.76%17M | -75.57%17.5M | -49.70%31M | 1.62%62.63M |
| Long term account payable | ---- | --0 | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 |
| Long term salaries pay | -9.89%756K | -9.89%756K | -10.44%772K | -10.44%772K | -27.42%839K | -27.42%839K | -28.29%862K | -28.29%862K | -8.40%1.16M | -8.40%1.16M |
| Specific account payable | ---- | 0.00%6.94M | ---- | ---- | ---- | 0.00%6.94M | ---- | 0.00%6.94M | ---- | 0.00%6.94M |
| Estimate liabilities | --5.4M | --5.4M | --2.84M | --2.84M | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | -9.59%134.74M | -9.28%139.62M | -9.93%141.21M | -6.66%146.05M | -9.35%149.03M | -8.67%153.91M | -9.08%156.78M | -11.07%156.48M | -14.56%164.4M | -15.95%168.52M |
| Long term deferred income | -7.46%70M | -7.48%71.38M | -7.46%72.77M | -7.41%74.17M | -10.34%75.65M | -7.67%77.14M | -7.51%78.63M | -7.83%80.11M | -4.47%84.37M | -8.50%83.55M |
| Lease liabilities | 13.69%1.56B | 23.32%1.66B | 25.19%1.64B | 9.37%1.45B | 1.03%1.37B | -2.98%1.35B | -7.66%1.31B | -3.49%1.33B | -4.08%1.36B | 2.23%1.39B |
| Other non current liabilities | -23.32%456.85M | -18.32%494.36M | 0.55%517.35M | 3.30%572.47M | -15.70%595.8M | -12.98%605.26M | -12.04%514.53M | -16.59%554.16M | 15.58%706.77M | 10.26%695.54M |
| Total non current liabilities | 1.55%2.23B | 8.15%2.38B | 14.26%2.38B | 5.21%2.26B | -6.48%2.2B | -8.56%2.2B | -10.88%2.09B | -10.03%2.14B | -3.84%2.35B | -0.51%2.41B |
| Total liabilities | 0.18%30.33B | 0.90%30.06B | 7.53%30.11B | 14.77%26.59B | 6.16%30.27B | 8.56%29.79B | 5.55%28B | -6.42%23.17B | 5.39%28.51B | 2.76%27.44B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%556.57M | 0.00%556.57M | 30.00%556.57M | 30.00%556.57M | 30.00%556.57M | 30.00%556.57M | 0.00%428.13M | 0.00%428.13M | 0.00%428.13M | 0.00%428.13M |
| Capital reserve funds | 0.76%4.26B | 0.76%4.26B | -2.21%4.26B | -2.21%4.26B | -3.28%4.23B | -3.28%4.23B | -0.34%4.36B | -0.34%4.36B | -0.00%4.37B | -0.01%4.37B |
| Surplus reserve funds | 30.00%278.28M | 30.00%278.28M | 30.00%278.28M | 30.00%278.28M | 0.00%214.06M | 0.00%214.06M | 0.00%214.06M | 0.00%214.06M | 0.00%214.06M | 0.00%214.06M |
| Retained profit | 8.63%13B | 9.22%12.68B | 10.62%12.7B | 10.73%12.31B | 12.04%11.97B | 12.62%11.61B | 13.21%11.48B | 12.44%11.12B | 10.94%10.68B | 10.89%10.31B |
| Other composite income | -0.62%7.85M | -0.62%7.85M | -0.51%7.87M | -0.57%7.87M | -64.09%7.9M | -63.87%7.9M | -63.96%7.91M | -63.83%7.91M | -42.98%22.01M | -43.26%21.87M |
| Shareholders equity without minority interests | 6.65%18.1B | 7.02%17.78B | 7.98%17.8B | 7.99%17.41B | 8.00%16.97B | 8.29%16.61B | 8.64%16.49B | 8.05%16.13B | 7.06%15.72B | 6.94%15.34B |
| Minority interests | 1.70%3.55B | 2.54%3.57B | 6.37%3.62B | 7.36%3.56B | 8.10%3.49B | 9.18%3.48B | 8.26%3.4B | 7.15%3.32B | 3.60%3.23B | 1.48%3.19B |
| Total shareholder equity | 5.81%21.65B | 6.24%21.35B | 7.70%21.42B | 7.88%20.98B | 8.02%20.47B | 8.44%20.09B | 8.57%19.89B | 7.89%19.44B | 6.45%18.95B | 5.96%18.53B |
| Total liabilityies and equity | 2.45%51.98B | 3.05%51.41B | 7.60%51.52B | 11.63%47.57B | 6.90%50.74B | 8.51%49.88B | 6.78%47.89B | -0.39%42.62B | 5.81%47.46B | 4.02%45.97B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
